What is the purpose of the medicine plerixafor?
Patients with specific types of cancer (non-lymphoma-NHL, Hodgkin’s multiple myeloma-MM) are given plerixafor to help them prepare for stem cell transplants. Red blood cells, white blood cells, and platelets are all formed by stem cells, which are located mostly in the bone marrow.
Is Celstam X a chemotherapeutic agent?
Celstam X is a more effective and less toxic mobilizing agent than conventional chemotherapy (particularly in strongly pretreated patients), with equivalent subsequent prognosis, and merits consideration as the first-line standard of care for stem cell mobilization.
What are the plerixafor side effects?
- Mild to moderate bone pain is the most prevalent side effect of plerixafor®.
- Fever, diarrhea, skin rash, and weakness are all possible side effects of plerixafor®.
- Patients taking plerixafor® may experience spleen enlargement and rupture on rare occasions. For more details Click Here.
Plerixafor is administered in a variety of ways.
- Mozobil administration
- After the patient has received G-CSF once daily for four days1, start Mozobil medication.
- For up to 4 days1, administer Mozobil approximately 11 hours prior to the start of each apheresis session.
What is the best time to take Plerixafor?
Start taking the drug at least 24 hours after your chemotherapy has finished. However, do not take it within 24 hours of starting another chemotherapy treatment. Allow 30 minutes for the drug to come to room temperature before injecting it.
What is an autologous stem cell transplant and how does it work?
An autologous stem cell transplant uses healthy blood stem cells from your own body to replace defective or damaged bone marrow. An autologous bone marrow transplant is similar to an autologous stem cell transplant in that it uses the patient’s own cells.
What is the best time to take Mozobil?
Mozobil is exclusively used in people who have trouble collecting stem cells and is combined with the hormone granulocyte-colony stimulating factor (G-CSF). Adults with lymphoma or multiple myeloma (blood cancers) are among those who receive Mozobil.
Mozobil is a type of medication.
Mozobil (plerixafor injection) is a hematopoietic stem cell mobilizer used in persons with non-lymphoma Hodgkin’s or multiple myeloma to help bone marrow release stem cells into the bloodstream so they can be harvested and reintroduced into the body